Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
Li-Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome caused by pathogenic germline variants in the TP53 gene, characterized by a predisposition to the development of a broad spectrum of tumors at an early age. The core tumors related to LFS are bone and soft tissue sarc...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5faa01362f1d4910bee4c50e4ee2336c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5faa01362f1d4910bee4c50e4ee2336c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5faa01362f1d4910bee4c50e4ee2336c2021-12-02T20:08:13ZClinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.1932-620310.1371/journal.pone.0251639https://doaj.org/article/5faa01362f1d4910bee4c50e4ee2336c2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0251639https://doaj.org/toc/1932-6203Li-Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome caused by pathogenic germline variants in the TP53 gene, characterized by a predisposition to the development of a broad spectrum of tumors at an early age. The core tumors related to LFS are bone and soft tissue sarcomas, premenopausal breast cancer, brain tumors, adrenocortical carcinomas (ACC), and leukemias. The revised Chompret criteria has been widely used to establish clinical suspicion and support TP53 germline variant testing and LFS diagnosis. Information on TP53 germline pathogenic variant (PV) prevalence when using Chompret criteria in South America and especially in Brazil is scarce. Therefore, the aim of this study was to characterize patients that fulfilled these specific criteria in southern Brazil, a region known for its high population frequency of a founder TP53 variant c.1010G>A (p.Arg337His), as known as R337H. TP53 germline testing of 191 cancer-affected and independent probands with LFS phenotype identified a heterozygous pathogenic/likely pathogenic variant in 26 (13.6%) probands, both in the DNA binding domain (group A) and in the oligomerization domain (group B) of the gene. Of the 26 carriers, 18 (69.23%) were R337H heterozygotes. Median age at diagnosis of the first tumor in groups A and B differed significantly in this cohort: 22 and 2 years, respectively (P = 0.009). The present study shows the clinical heterogeneity of LFS, highlights particularities of the R337H variant and underscores the need for larger collaborative studies to better define LFS prevalence, clinical spectrum and penetrance of different germline TP53 pathogenic variants.Camila Matzenbacher BittarYasminne Marinho de Araújo RochaIgor Araujo VieiraClévia RossetTiago Finger AndreisIvaine Tais Sauthier SartorOsvaldo ArtigalásCristina B O NettoBarbara AlemarGabriel S MacedoPatricia Ashton-ProllaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0251639 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Camila Matzenbacher Bittar Yasminne Marinho de Araújo Rocha Igor Araujo Vieira Clévia Rosset Tiago Finger Andreis Ivaine Tais Sauthier Sartor Osvaldo Artigalás Cristina B O Netto Barbara Alemar Gabriel S Macedo Patricia Ashton-Prolla Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. |
| description |
Li-Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome caused by pathogenic germline variants in the TP53 gene, characterized by a predisposition to the development of a broad spectrum of tumors at an early age. The core tumors related to LFS are bone and soft tissue sarcomas, premenopausal breast cancer, brain tumors, adrenocortical carcinomas (ACC), and leukemias. The revised Chompret criteria has been widely used to establish clinical suspicion and support TP53 germline variant testing and LFS diagnosis. Information on TP53 germline pathogenic variant (PV) prevalence when using Chompret criteria in South America and especially in Brazil is scarce. Therefore, the aim of this study was to characterize patients that fulfilled these specific criteria in southern Brazil, a region known for its high population frequency of a founder TP53 variant c.1010G>A (p.Arg337His), as known as R337H. TP53 germline testing of 191 cancer-affected and independent probands with LFS phenotype identified a heterozygous pathogenic/likely pathogenic variant in 26 (13.6%) probands, both in the DNA binding domain (group A) and in the oligomerization domain (group B) of the gene. Of the 26 carriers, 18 (69.23%) were R337H heterozygotes. Median age at diagnosis of the first tumor in groups A and B differed significantly in this cohort: 22 and 2 years, respectively (P = 0.009). The present study shows the clinical heterogeneity of LFS, highlights particularities of the R337H variant and underscores the need for larger collaborative studies to better define LFS prevalence, clinical spectrum and penetrance of different germline TP53 pathogenic variants. |
| format |
article |
| author |
Camila Matzenbacher Bittar Yasminne Marinho de Araújo Rocha Igor Araujo Vieira Clévia Rosset Tiago Finger Andreis Ivaine Tais Sauthier Sartor Osvaldo Artigalás Cristina B O Netto Barbara Alemar Gabriel S Macedo Patricia Ashton-Prolla |
| author_facet |
Camila Matzenbacher Bittar Yasminne Marinho de Araújo Rocha Igor Araujo Vieira Clévia Rosset Tiago Finger Andreis Ivaine Tais Sauthier Sartor Osvaldo Artigalás Cristina B O Netto Barbara Alemar Gabriel S Macedo Patricia Ashton-Prolla |
| author_sort |
Camila Matzenbacher Bittar |
| title |
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. |
| title_short |
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. |
| title_full |
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. |
| title_fullStr |
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. |
| title_full_unstemmed |
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. |
| title_sort |
clinical and molecular characterization of patients fulfilling chompret criteria for li-fraumeni syndrome in southern brazil. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2021 |
| url |
https://doaj.org/article/5faa01362f1d4910bee4c50e4ee2336c |
| work_keys_str_mv |
AT camilamatzenbacherbittar clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT yasminnemarinhodearaujorocha clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT igoraraujovieira clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT cleviarosset clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT tiagofingerandreis clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT ivainetaissauthiersartor clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT osvaldoartigalas clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT cristinabonetto clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT barbaraalemar clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT gabrielsmacedo clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil AT patriciaashtonprolla clinicalandmolecularcharacterizationofpatientsfulfillingchompretcriteriaforlifraumenisyndromeinsouthernbrazil |
| _version_ |
1718375184693460992 |